
Kanseri y'ibihaha ya Neuroendocrine ni ubwoko bwa kanseri y'ibihaha idasanzwe ikomoka mu ngirabuzimafatizo ya neuroendocrine y'ibihaha. Iki gitabo cyuzuye kirasobanura uburyo butandukanye bwo kuvura kuvura kanseri y'ibihaha ya neuroendocrine, ushimangira akamaro ko kwita kubantu kugiti cyabo hamwe niterambere rigezweho murwego. Gusobanukirwa umwihariko w'isuzuma ryawe no gukorana bya hafi na oncologue wawe ni ngombwa mugutegura gahunda nziza yo kuvura.
Kanseri y'ibihaha ya Neuroendocrine ishyirwa mu bwoko butandukanye ukurikije imiterere ya selile n'imiterere yo gukura. Harimo kanseri isanzwe, kanseri idasanzwe, kanseri nini ya neuroendocrine kanseri, na kanseri ntoya y'ibihaha (SCLC). Ubwoko bwa kanseri y'ibihaha ya neuroendocrine bigira uruhare runini muburyo bwo kuvura.
Gutegura bikubiyemo kumenya urugero rwa kanseri ikwirakwira. Ibi mubisanzwe bikorwa binyuze mumashusho yerekana amashusho (CT scan, PET scan) kandi birashobora kuba birimo biopsy. Gutegura ni ngombwa muguhitamo igikwiye kuvura kanseri y'ibihaha ya neuroendocrine no guhanura ibizaba.
Kubaga akenshi nubuvuzi bwibanze kubwa mbere kanseri y'ibihaha ya neuroendocrine, cyane cyane kubyimba byaho. Ubwoko bwo kubaga buterwa n'ahantu hamwe n'ubunini bw'ikibyimba. Tekinike yibasiwe cyane akenshi ikundwa mugihe bishoboka.
Chimoterapi ikoresha imiti yica kanseri. Irashobora gukoreshwa wenyine cyangwa ifatanije nubundi buvuzi. Imiti yihariye ya chimiotherapie iterwa nubwoko nicyiciro cya kanseri y'ibihaha ya neuroendocrine. Imiti ikoreshwa cyane ya chimiotherapeutique irimo karboplatine na etoposide ya SCLC.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa mu kugabanya ibibyimba, kugabanya ibimenyetso, cyangwa kwirinda kanseri. Imiti ivura imirasire yo hanze ikoreshwa cyane, ariko brachytherapy (imirasire yimbere) nayo irashobora guhitamo.
Ubuvuzi bugamije gukoresha imiti yibasira molekile zihariye zigira uruhare mu mikurire ya kanseri no kubaho. Ubu buryo bwo kuvura bukora neza kandi bukagira ingaruka nke ugereranije na chimiotherapie gakondo. Kuboneka kubuvuzi bugenewe kuri kuvura kanseri y'ibihaha ya neuroendocrine biterwa n'ubwoko bwihariye hamwe na genetique yibibyimba. Ingero zirimo inhibitor zigamije reseptor tyrosine kinase.
Immunotherapy ikoresha imbaraga z'umubiri urwanya kanseri. Ikora mukubyutsa ubudahangarwa bw'umubiri kumenya no gutera kanseri. Immune igenzura, nka pembrolizumab na atezolizumab, bagaragaje amasezerano yo kuvura ubwoko bumwe na bumwe kanseri y'ibihaha ya neuroendocrine.
Ibyiza kuvura kanseri y'ibihaha ya neuroendocrine gahunda iratandukanye cyane kandi biterwa nibintu bitandukanye, harimo ubwoko nicyiciro cya kanseri, ubuzima bwumurwayi muri rusange, hamwe nibyo akunda. Ubufatanye bwa hafi na oncologue w'inararibonye ni ngombwa mugutegura ingamba zihariye zo kuvura. Kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri, duharanira gutanga ubuvuzi bwuzuye kandi bwimpuhwe kubarwayi bacu bose.
Kumenyekanisha kuri kanseri y'ibihaha ya neuroendocrine biratandukanye cyane bitewe n'ubwoko bwa kanseri, hamwe n'ubuzima bw'umurwayi muri rusange. Gahunda isanzwe ikurikirana ningirakamaro mugukurikirana imikorere yubuvuzi no kumenya ibizagaruka. Iyi gahunda mubisanzwe ikubiyemo ibizamini byo gufata amashusho hamwe nibizamini byumubiri.
Kubindi bisobanuro bijyanye kanseri y'ibihaha ya neuroendocrine nubuvuzi bwayo, baza muganga wawe cyangwa urebe amasoko azwi nkikigo cyigihugu cya kanseri (https://www.cancer.gov/). Buri gihe shyira imbere ibiganiro nabashinzwe ubuzima mbere yo gufata ibyemezo bijyanye no kwivuza.
| Ubwoko bwo kuvura | Ibyiza | Ibibi |
|---|---|---|
| Kubaga | Birashoboka kuvura kanseri yo hambere | Ntishobora kuba ibereye abarwayi bose cyangwa ibyiciro |
| Chimoterapi | Irashobora kugabanya ibibyimba no kunoza ibimenyetso | Ingaruka zo kuruhande zirashobora kuba ingirakamaro |
| Ubuvuzi | Irashobora kwibasira uduce tumwe na tumwe no kugabanya kwangirika kwinyama nzima | Irashobora gutera ingaruka nkumunaniro no kurwara uruhu |